Skip to main content
. 2023 Feb 17;23:98. doi: 10.1186/s12879-023-08071-9

Table 2.

Acceptability questionnaires in PWH and PrEP users

Variable HIV
N = 100
Prep
N = 100
P
Would accept LAA every other month, n (%) 74 (74) 89 (89) 0.001
Perceived advantages
 Stop taking cARTa-treatment every day, n (%) 73 (73) 73 (73)  > 0.99
 Being certain of efficacy for a period of time, n (%) 42 (42) 51 (51) 0.26
 Being certain not to forget cART-treatment, n (%) 39 (39) 68 (68)  < 0.0001
 Hiding that I take cART-treatment, n (%) 0 (0) 7 (7) 0.014
 No need to think of treatment every day, n (%) 28 (28) 62 (62)  < 0.0001
 Forget the disease, n (%) 19 (19)
 Other, n (%) 11 (11) 0 (0) 0.0007
 None, n (%) 11 (11) 0 (0) 0.0007
Perceived drawbacks
 Loss of freedom, n (%) 6 (6) 30 (30)  < 0.0001
 Fear of adverse effects, n (%) 29 (29) 47 (47) 0.013
 Fear of injections, n (%) 14 (14) 19 (19) 0.45
 Fear of being treated as a Guinea pig, n (%) 17 (17) 23 (23) 0.38
 It would not change anything, n (%) 9 (9) 8 (8)  > 0.99
 Already taking other treatments, n (%) 7 (7) 1 (1) 0.065
 Too much a constraint, n (%) 21 (21) 0 (0)  < 0.0001
 Other, n (%) 6 (6) 0 (0) 0.029
 None, n (%) 29 (29) 22 (22) 0.33
What do you feel about coming every other month?
 Beneficial because more follow-up, n (%) 23 (23) 28 (28) 0.52
 I don't like the idea of going more often to the hospital, n (%) 34 (34) 21 (21) 0.057
 I don't care, n (%) 42 (42) 53 (53) 0.16
About an injectable treatment?
 Do not wish to change my treatment, n (%) 23 (23) 12 (12) 0.062
 Accepts both injections and hospital visits, n (%) 35 (35) 58 (58) 0.002
 Accepts injections but not hospital visits, n (%) 29 (29) 21 (21) 0.25
 Accepts injections but fears adverse effects, n (%) 18 (18) 19 (19)  > 0.99
 Would like to switch to injections at specific times, n (%) 27 (27) 29 (29) 0.87
Would you accept participating to a clinical trial?
 Would not participate, n (%) 28 (28) 31 (31) 0.76
 Would accept injections at the hospital, n (%) 34 (34) 36 (36) 0.88
 Could accept injections if self-administered, n (%) 19 (19) 7 (7) 0.019

aART: combined antiretroviral therapies